SG Americas Securities LLC boosted its holdings in shares of Hims & Hers Health, Inc. (NYSE:HIMS – Free Report) by 44.0% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 104,422 shares of th
Source link
As Indian equity markets continue to evolve, some believe it’s time to revisit the methodology behind index composition, particularly in how weights are assigned to constituent stocks. The conversation is gaining momentum amid concerns that current weightings overly favor a handful of large-cap names, potentially leading to manipulation by large players in major indices like…
I get it! Investors hear over and over that dividend stocks with high yields can be a red flag. Yet some high-yield dividend stocks can still be good buys for decades. Not every big yield signals trouble, and in fact, sometimes it simply reflects a steady, mature business that throws off more cash than it…
Investing.com – Accenture (NYSE: ) reported fourth quarter EPS of $2.79, $0.01 better than the analyst estimate of $2.78. Revenue for the quarter came in at $16.4B versus the consensus estimate of $16.35B. Accenture’s stock price closed at $337.05. It is up 11.09% in the last 3 months and up 7.21% in the last 12…
Hello Alan,I am new to BCI, but I have read your books, and I am now paper trading to test what I have learned. I could not be happier with what I am learning from your books and from paper trading using your methodologies. After my first month of paper trading, I cannot understand…
President Donald Trump’s efforts to help the U.S. coal industry at home are being offset by falling sales abroad Source link
Shares of Aurobindo Pharma Ltd were trading 3% higher on 3 June after the company’s wholly-owned subsidiary, TheraNym Biologics, signed a master service agreement for contract manufacturing of biologicals with Merck Sharpe & Dohme Singapore. As a part of this agreement, TheraNym will produce biologics for both domestic and international markets on behalf of Merck…